Form 8-K - Current report:
SEC Accession No. 0001615219-25-000004
Filing Date
2025-01-13
Accepted
2025-01-13 08:09:31
Documents
98
Period of Report
2025-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20250110.htm   iXBRL 8-K 869785
2 EX-2.1 markedex21agreementandplan.htm EX-2.1 1099806
3 EX-4.1 ex41formofcertificateofdes.htm EX-4.1 95178
4 EX-10.1 ex101parentsupportagreement.htm EX-10.1 77370
5 EX-10.2 ex102formofdecoysupportagr.htm EX-10.2 77778
6 EX-10.3 ex103lock-upagreement.htm EX-10.3 45132
7 EX-10.4 ex104slrx-warrantcancellat.htm EX-10.4 51685
8 EX-23.1 markedex231-consentoffruci.htm EX-23.1 5796
9 EX-99.1 a991fs2022and2023.htm EX-99.1 97793
10 EX-99.2 a99209302024and2023.htm EX-99.2 86563
11 EX-99.3 ex993salarius-decoyproform.htm EX-99.3 283158
12 EX-99.4 a994definitiveagreemtpress.htm EX-99.4 24644
16 GRAPHIC a991fs2022and2023001.jpg GRAPHIC 38433
17 GRAPHIC a991fs2022and2023002.jpg GRAPHIC 54415
18 GRAPHIC a991fs2022and2023003.jpg GRAPHIC 293563
19 GRAPHIC a991fs2022and2023004.jpg GRAPHIC 109429
20 GRAPHIC a991fs2022and2023005.jpg GRAPHIC 110547
21 GRAPHIC a991fs2022and2023006.jpg GRAPHIC 78414
22 GRAPHIC a991fs2022and2023007.jpg GRAPHIC 73842
23 GRAPHIC a991fs2022and2023008.jpg GRAPHIC 114486
24 GRAPHIC a991fs2022and2023009.jpg GRAPHIC 269075
25 GRAPHIC a991fs2022and2023010.jpg GRAPHIC 234575
26 GRAPHIC a991fs2022and2023011.jpg GRAPHIC 203132
27 GRAPHIC a991fs2022and2023012.jpg GRAPHIC 234871
28 GRAPHIC a991fs2022and2023013.jpg GRAPHIC 249385
29 GRAPHIC a991fs2022and2023014.jpg GRAPHIC 229431
30 GRAPHIC a991fs2022and2023015.jpg GRAPHIC 292367
31 GRAPHIC a991fs2022and2023016.jpg GRAPHIC 309694
32 GRAPHIC a991fs2022and2023017.jpg GRAPHIC 309418
33 GRAPHIC a991fs2022and2023018.jpg GRAPHIC 288348
34 GRAPHIC a991fs2022and2023019.jpg GRAPHIC 280596
35 GRAPHIC a991fs2022and2023020.jpg GRAPHIC 205672
36 GRAPHIC a991fs2022and2023021.jpg GRAPHIC 147374
37 GRAPHIC a991fs2022and2023022.jpg GRAPHIC 176582
38 GRAPHIC a991fs2022and2023023.jpg GRAPHIC 144144
39 GRAPHIC a991fs2022and2023024.jpg GRAPHIC 131257
40 GRAPHIC a991fs2022and2023025.jpg GRAPHIC 196406
41 GRAPHIC a991fs2022and2023026.jpg GRAPHIC 165128
42 GRAPHIC a991fs2022and2023027.jpg GRAPHIC 143834
43 GRAPHIC a991fs2022and2023028.jpg GRAPHIC 220161
44 GRAPHIC a991fs2022and2023029.jpg GRAPHIC 106863
45 GRAPHIC a99209302024and2023001.jpg GRAPHIC 40510
46 GRAPHIC a99209302024and2023002.jpg GRAPHIC 52500
47 GRAPHIC a99209302024and2023003.jpg GRAPHIC 108137
48 GRAPHIC a99209302024and2023004.jpg GRAPHIC 78859
49 GRAPHIC a99209302024and2023005.jpg GRAPHIC 89781
50 GRAPHIC a99209302024and2023006.jpg GRAPHIC 105691
51 GRAPHIC a99209302024and2023007.jpg GRAPHIC 269067
52 GRAPHIC a99209302024and2023008.jpg GRAPHIC 256290
53 GRAPHIC a99209302024and2023009.jpg GRAPHIC 225104
54 GRAPHIC a99209302024and2023010.jpg GRAPHIC 230938
55 GRAPHIC a99209302024and2023011.jpg GRAPHIC 235689
56 GRAPHIC a99209302024and2023012.jpg GRAPHIC 228727
57 GRAPHIC a99209302024and2023013.jpg GRAPHIC 300748
58 GRAPHIC a99209302024and2023014.jpg GRAPHIC 310084
59 GRAPHIC a99209302024and2023015.jpg GRAPHIC 293802
60 GRAPHIC a99209302024and2023016.jpg GRAPHIC 300781
61 GRAPHIC a99209302024and2023017.jpg GRAPHIC 255476
62 GRAPHIC a99209302024and2023018.jpg GRAPHIC 215182
63 GRAPHIC a99209302024and2023019.jpg GRAPHIC 147422
64 GRAPHIC a99209302024and2023020.jpg GRAPHIC 185655
65 GRAPHIC a99209302024and2023021.jpg GRAPHIC 122942
66 GRAPHIC a99209302024and2023022.jpg GRAPHIC 145919
67 GRAPHIC a99209302024and2023023.jpg GRAPHIC 201469
68 GRAPHIC a99209302024and2023024.jpg GRAPHIC 166486
69 GRAPHIC a99209302024and2023025.jpg GRAPHIC 173786
70 flks-20250110_g1.jpg GRAPHIC 99476
71 flks-20250110_g10.jpg GRAPHIC 21530
72 flks-20250110_g11.jpg GRAPHIC 157870
73 flks-20250110_g12.jpg GRAPHIC 126193
74 flks-20250110_g13.jpg GRAPHIC 40556
75 flks-20250110_g14.jpg GRAPHIC 47578
76 flks-20250110_g15.jpg GRAPHIC 177035
77 flks-20250110_g16.jpg GRAPHIC 50714
78 flks-20250110_g17.jpg GRAPHIC 22990
79 flks-20250110_g2.jpg GRAPHIC 33543
80 flks-20250110_g3.jpg GRAPHIC 71966
81 flks-20250110_g4.jpg GRAPHIC 200359
82 flks-20250110_g5.jpg GRAPHIC 122153
83 flks-20250110_g6.jpg GRAPHIC 57570
84 flks-20250110_g7.jpg GRAPHIC 59209
85 flks-20250110_g8.jpg GRAPHIC 136099
86 flks-20250110_g9.jpg GRAPHIC 164641
87 image_0.jpg GRAPHIC 35128
88 image_0b.jpg GRAPHIC 8088
89 image_1.jpg GRAPHIC 44097
  Complete submission text file 0001615219-25-000004.txt   21597566

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250110.xsd EX-101.SCH 1807
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250110_lab.xml EX-101.LAB 21689
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250110_pre.xml EX-101.PRE 12543
100 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250110_htm.xml XML 2721
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 25524921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)